Trexquant Investment’s OptimizeRx OPRX Stock Holding History

Trexquant Investment’s Portfolio OPRX Stock Details OPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$513K	Sell	89,666 -47,208	-34%	-$271K	﹤0.01%	1636
2026 Q1	$860K	Buy	+136,874	New	+$1.27M	0.01%	1281
2025 Q3	–	Sell	-11,257	Closed	-$152K	–	1820
2025 Q2	$152K	Sell	11,257 -43,005	-79%	-$470K	﹤0.01%	1463
2025 Q1	$470K	Buy	+54,262	New	+$332K	0.01%	1290
2023 Q1	–	Sell	-28,708	Closed	-$482K	–	1678
2022 Q4	$482K	Buy	+28,708	New	+$496K	0.01%	927
2021 Q2	–	Sell	-5,309	Closed	-$259K	–	1385
2021 Q1	$259K	Buy	+5,309	New	+$256K	0.02%	827
2020 Q4	–	Sell	-17,395	Closed	-$363K	–	1369
2020 Q3	$363K	Buy	+17,395	New	+$299K	0.02%	847

Other funds holding OPRX

WCA

Whetstone Capital Advisors Shawnee Mission, Kansas $380M AUM 20.01% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

KCM

Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

Trexquant Investment's OPRX Position: Q2 2026 in Review

Trexquant Investment reduced its OptimizeRx (OPRX) stake by 34% in Q2 2026, selling an estimated $271K and leaving 89,666 shares worth $513K. The position accounts for ﹤0.01% of the portfolio, ranked #1636.

Trexquant Investment first reported a position in OPRX in Q3 2020 and has held it in 7 quarters since. The position peaked at $860K in Q1 2026. 112 funds tracked by Wall St. Rank hold OPRX as of Q2 2026.

Trexquant Investment held 89,666 shares of OptimizeRx worth $513K as of Q2 2026.
Trexquant Investment sold 47,208 OptimizeRx shares in Q2 2026, an estimated $271K.
OptimizeRx made up ﹤0.01% of Trexquant Investment's portfolio in Q2 2026, its #1636 holding.
Trexquant Investment first reported a position in OptimizeRx in Q3 2020 and has held it in 7 quarters since.
Trexquant Investment's OptimizeRx position peaked at $860K in Q1 2026.
112 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.